6.68 +0.02 (0.30%)
PARD
Stock Details
Last Trade:6.68 Change:+0.02 (0.30%) Prev Close:6.66 Open: 6.60 Days Range:6.50 – 7.10 52 Week Range: 1.05 - 7.16 Volume:897590 P/E: N/AEPS:-1.41
View AllRecent Alerts 07/04/09
Recent Alert on 07/02/09 at 8:23am
Brean Murray Starts Poniard Pharmaceuticals (PARD) with a Buy
Brean Murray Starts Poniard Pharmaceuticals (PARD) with a Buy
Brean Murray initiates coverage on Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) with a Buy rating and $11 price target. The price target is derived by applying a 30 multiple and 35% discount rate to our 2013 EPS projection of $1.03, which assumes... Read More
Recent Alert on 06/05/09 at 3:51pm
Wedbush Morgan Maintains a 'Buy' on Poniard Pharmaceuticals (PARD); Renewed Interest in Emerging Pharma Sector - Raises Price Target
Wedbush Morgan Maintains a 'Buy' on Poniard Pharmaceuticals (PARD); Renewed Interest in Emerging Pharma Sector - Raises Price Target
Recent Alert on 05/28/09 at 9:41am
Morning Movers 5/28: FREE, EXEL, ANPI, GBE, PARD Higher; SPRD, NZ, PHHM, DSW, REV Lower
Morning Movers 5/28: FREE, EXEL, ANPI, GBE, PARD Higher; SPRD, NZ, PHHM, DSW, REV Lower
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/19/09 at 8:36am
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Blog Posts on 03/18/09 at 11:10am
Analyst upgrades, downgrades and initiations: CBRL, INTC, LLY, RDS.A, NTDOY ...
Analyst upgrades, downgrades and initiations: CBRL, INTC, LLY, RDS.A, NTDOY ...